Pharmacy Technician Certification Exams — Master The Pharmacy Technician Certification Exam PTCE
1. When used on a prescription IV may refer to either a route of administration or a:
Answer: C
IV may refer to either a route of administration or a dosage form.
In the context of a prescription, IV can indicate both the method of delivery (intravenous) and the specific formulation of the medication used for that delivery, which is classified as a dosage form.
A) Quantity
Quantity refers to the amount of medication prescribed but does not align with the definition of IV as it does not encompass the aspect of medication formulation or method of delivery.
B) Indication
Indication pertains to the reason a medication is prescribed, such as a specific medical condition. While relevant in a prescription context, it does not relate to the definition of IV in terms of administration or formulation.
C) Dosage form
Dosage form is the correct interpretation of what IV may also refer to in a prescription context. It encompasses the physical form of the medication intended for administration, such as solutions, emulsions, or suspensions, which are critical when administering via intravenous route.
D) Concentration
Concentration indicates the strength of the medication in a given volume but does not directly relate to the broader classification of dosage forms or the method of administration indicated by IV.
Conclusion
The correct answer is C) Dosage form, as it directly correlates with the context of intravenous administration, indicating the specific formulation of the medication. Other options, while relevant in a medical prescription context, do not capture the dual meaning of IV as effectively as dosage form does.
2. The prescription notation "ac" means:
Answer: A
The prescription notation "ac" means before meals.
The abbreviation "ac" is derived from the Latin phrase "ante cibum," which translates to "before meals." This notation is commonly used in medical prescriptions to indicate the timing of medication intake in relation to meals.
A) before meals.
This option is correct as "ac" specifically denotes that a medication should be taken before meals, aligning with the Latin origin of the abbreviation.
B) each ear.
This option is incorrect. The notation for "each ear" is typically represented as "au" (auris utraque) in medical prescriptions, which has no relation to "ac."
C) after meals.
This option is incorrect as "after meals" is denoted by the abbreviation "pc" (post cibum). Therefore, it does not represent the meaning of "ac."
D) right eye.
This option is also incorrect. The notation for "right eye" is usually represented as "od" (oculus dexter). Thus, it does not correspond to "ac" in any way.
Conclusion
The correct answer, "before meals," accurately reflects the meaning of the prescription notation "ac." The other options fail to capture the intended timing associated with medication administration, which is crucial for ensuring proper therapeutic outcomes. Understanding these abbreviations is essential for effective communication in clinical settings.
3. Which of the following is an effective error prevention strategy during medication order entry?
Answer: B
Being aware of easily misinterpreted abbreviations is an effective error prevention strategy during medication order entry.
Being aware of easily misinterpreted abbreviations helps healthcare professionals avoid potential medication errors. Recognizing and understanding these abbreviations can significantly reduce the risk of miscommunication and ensure patient safety in medication orders.
A) Running a drug expense report
Running a drug expense report is primarily a financial management tool that does not directly contribute to preventing medication errors during order entry. While it can provide insights into spending and inventory management, it does not address the accuracy or clarity of medication orders themselves.
B) Being aware of easily misinterpreted abbreviations
Being aware of easily misinterpreted abbreviations is crucial for preventing medication errors. Many medications and dosages can be confused due to similar abbreviations, and understanding these can lead to more accurate prescriptions and safer patient outcomes.
C) Reviewing controlled substance inventory
Reviewing controlled substance inventory is important for compliance and safety, but it does not specifically prevent errors during the medication order entry process. This strategy focuses more on tracking and managing controlled substances rather than ensuring the correct medications are ordered.
D) Using automated dispensing systems
Using automated dispensing systems can enhance medication safety by reducing human error in dispensing. However, while these systems can help prevent errors in the dispensing phase, they do not directly address issues that may arise during the initial medication order entry.
Conclusion
Being aware of easily misinterpreted abbreviations is definitively the most effective error prevention strategy during medication order entry, as it directly impacts communication accuracy. The other options, while valuable in their own contexts, do not specifically target the prevention of errors at the point of order entry, thereby making them less effective for this particular purpose.
Answer: A
Nitroglycerin SL is exempt from the Poison Prevention Packaging Act.
Nitroglycerin sublingual (SL) tablets are specifically exempt from the requirements of the Poison Prevention Packaging Act due to their unique therapeutic use and the need for rapid access in emergencies.
A) Nitroglycerin SL
This option is correct as nitroglycerin SL is explicitly exempt from child-resistant packaging requirements under the Poison Prevention Packaging Act. The exemption is granted because nitroglycerin is often used for acute angina attacks, and patients need immediate access to the medication.
B) Atenolol
Atenolol is not exempt from the Poison Prevention Packaging Act. It is a prescription medication used to treat high blood pressure and other cardiovascular conditions, and it requires child-resistant packaging to prevent accidental ingestion by children.
C) Amoxicillin
Amoxicillin is also not exempt from the Poison Prevention Packaging Act. As a commonly prescribed antibiotic, it is essential to package it in a child-resistant manner to minimize the risk of accidental poisoning among children.
D) Glipizide
Glipizide, which is used to manage blood sugar levels in diabetes, is similarly not exempt from the Poison Prevention Packaging Act. Like many oral medications, it is necessary to package glipizide in child-resistant containers to protect children from potential harm.
Conclusion
In summary, nitroglycerin SL is the only medication listed that is exempt from the Poison Prevention Packaging Act due to its critical use in emergency situations. The other options, atenolol, amoxicillin, and glipizide, must be packaged in child-resistant containers to ensure safety and prevent accidental ingestion by children. This highlights the importance of tailoring packaging requirements based on the specific use and risks associated with each medication.
Answer: C
Pharmacies must order stock bottles of Morphine using CSOS or a paper equivalent according to federal law.
Pharmacies are required to order stock bottles of Morphine using the Controlled Substance Ordering System (CSOS) or a paper equivalent, as it is classified as a Schedule II controlled substance under federal law.
A) Carisoprodol
Carisoprodol is not classified as a Schedule II controlled substance; it is a Schedule IV substance. Therefore, it does not require the same stringent ordering process as Morphine. Pharmacies can order Carisoprodol using standard ordering methods without the necessity of CSOS.
B) Tramadol
Tramadol is classified as a Schedule IV controlled substance, which means it has a lower potential for abuse compared to Schedule II drugs. Consequently, pharmacies do not need to use CSOS or a paper equivalent to order Tramadol, making this option incorrect.
C) Morphine
Morphine is classified as a Schedule II controlled substance, and federal law mandates that pharmacies must use CSOS or a paper equivalent to order it. This requirement is in place due to the high potential for abuse associated with Morphine.
D) Buprenorphine
Buprenorphine is classified as a Schedule III controlled substance, which means it does not have the same ordering requirements as Schedule II substances like Morphine. Pharmacies can order Buprenorphine through regular ordering channels without the need for CSOS.
Conclusion
Morphine is the only medication listed that requires pharmacies to use CSOS or a paper equivalent for ordering due to its classification as a Schedule II controlled substance. In contrast, Carisoprodol, Tramadol, and Buprenorphine fall under different scheduling categories that do not impose the same stringent requirements, confirming that option C is definitively correct.
6. Most likely to cause actual patient harm:
Answer: A
Patient already took wrong medication for several doses
The situation where a patient has already taken the wrong medication for several doses poses the highest risk of actual patient harm. This scenario indicates a prolonged exposure to potentially harmful medication, which could lead to serious adverse effects or complications.
A) patient already took wrong medication for several doses
This option is the most critical because the patient has already been exposed to the incorrect medication multiple times, increasing the likelihood of severe health consequences. The cumulative effects of the wrong medication can lead to significant harm, including worsening of the patient's condition or new health issues arising from the improper treatment.
B) wrong instructions caught at counseling
While providing wrong instructions can lead to patient confusion or misuse of medication, catching these errors during counseling allows for correction before any harm occurs. Therefore, this option is less likely to result in actual patient harm compared to a patient having already taken the wrong medication.
C) tech finds unverified Rx
The discovery of an unverified prescription by a technician is a concerning situation, but it does not inherently lead to patient harm unless the prescription is filled and administered. This option indicates a potential for error but does not directly result in harm to a patient who has not yet received the medication.
D) tech finds Rx in wrong bag
Finding a prescription in the wrong bag is an important error that needs addressing, yet it does not cause harm unless the medication is dispensed to the wrong patient. This situation highlights a logistical issue rather than a direct threat to patient safety until the medication is misadministered.
Conclusion
The scenario where a patient has already taken the wrong medication for several doses is definitively the most harmful, as it involves the actual ingestion of incorrect medication over time. In contrast, the other options primarily represent potential errors that can be corrected before causing harm, making them significantly less critical in terms of immediate patient safety.
Answer: B
The technician should refer to beyond-use dating guidelines found in USP Chapter 795.
USP Chapter 795 provides guidelines for the compounding of non-sterile preparations, including the assignment of beyond-use dates. This chapter outlines the appropriate practices and considerations that must be taken into account when determining how long a compounded preparation remains safe and effective for patient use.
A) 37
USP Chapter 37 does not exist in the context of compounding guidelines. Therefore, it cannot provide relevant information regarding beyond-use dating for compounded medications.
B) 795
USP Chapter 795 specifically addresses the compounding of non-sterile preparations and includes detailed guidance on assigning beyond-use dates. This makes it the correct reference for the pharmacy technician in this scenario.
C) 797
USP Chapter 797 deals with the compounding of sterile preparations, focusing on practices that ensure the safety and quality of injectable and other sterile products. While important, it does not pertain to beyond-use dating for non-sterile formulations.
D) 800
USP Chapter 800 provides guidelines related to the handling of hazardous drugs in healthcare settings. Although it is vital for safety practices, it does not address beyond-use dating for compounded preparations.
Conclusion
The technician should rely on USP Chapter 795 for guidance on beyond-use dating for the compounded tretinoin oral suspension, as it specifically covers non-sterile compounding practices. The other options (37, 797, and 800) do not provide relevant information regarding the assignment of beyond-use dates, making them incorrect choices in this context.
8. According to DSCSA, when a shipment is suspected to be illegitimate, the first step is to:
Answer: D
The first step when a shipment is suspected to be illegitimate is to quarantine it at the pharmacy.
Quarantining the shipment at the pharmacy ensures that it is isolated from legitimate inventory while further investigation is conducted. This step is critical to prevent potential harm from illegitimate products entering the supply chain.
A) return it to the original source.
Returning the shipment to the original source may not be the immediate or safest action when a product is suspected to be illegitimate. This process could inadvertently allow potentially harmful products to re-enter circulation without proper evaluation.
B) return it to the previous supplier.
Similar to option A, returning the shipment to the previous supplier does not address the immediate need to ensure safety and compliance. It could also risk reintroducing the illegitimate product into the supply chain without appropriate checks.
C) dispose of it at the pharmacy.
Disposing of the shipment at the pharmacy is not the first step outlined in DSCSA protocols. Disposal may be necessary later, but the priority is to quarantine the product for further assessment before any disposal action is taken.
D) quarantine it at the pharmacy.
Quarantining the shipment is the correct initial action according to DSCSA guidelines. This step prevents the shipment from being mixed with legitimate products, allowing for a thorough investigation into its legitimacy without risking public health.
Conclusion
Quarantining the shipment is essential to uphold safety standards and follow proper protocols when dealing with suspected illegitimate products. While other options involve returning or disposing of the product, they fail to provide the necessary immediate protection and assessment needed in such situations. Thus, option D is the definitive correct answer.
9. Prior to dispensing, it would be most appropriate to store Humira:
Answer: B
Humira should be stored in a refrigerator, at 2°C to 8°C (36°F to 46°F).
Storing Humira in a refrigerator at the specified temperature range ensures the medication remains effective and safe for use. This temperature range is crucial for maintaining the stability and potency of the biologic drug.
A) in a freezer, at -20°C to -10°C (-4°F to 14°F)
Storing Humira in a freezer is incorrect as freezing can damage the medication and alter its efficacy. Biologics like Humira are sensitive to temperature extremes, and freezing can lead to protein denaturation, rendering the drug ineffective.
B) in a refrigerator, at 2°C to 8°C (36°F to 46°F)
This option is correct as Humira is specifically recommended to be stored in a refrigerator within this temperature range. This condition helps preserve the medication's stability and potency until it is ready to be dispensed and administered.
C) cool, at 8°C to 15°C (46°F to 59°F)
While this option describes a cool range, it is not optimal for Humira storage. The recommended storage temperature is lower, specifically between 2°C to 8°C, to ensure its effectiveness and avoid any potential degradation.
D) at room temperature, at 15°C to 30°C (59°F to 86°F)
Storing Humira at room temperature is unsuitable as it exceeds the recommended storage temperature. Exposure to higher temperatures can compromise the drug's stability and effectiveness, which could potentially lead to treatment failures.
Conclusion
The appropriate storage of Humira is critical for maintaining its efficacy, and the correct answer, storing it in a refrigerator at 2°C to 8°C, aligns with established guidelines. All other options present temperature ranges that could jeopardize the drug's stability and patient safety, making them unsuitable for proper storage.
10. Which of the following should be included in the administration instructions for alendronate?
Answer: A
Do not lie down for at least 30 minutes
Alendronate administration instructions specify that patients should not lie down for at least 30 minutes after taking the medication. This helps to minimize the risk of esophageal irritation and ensures proper absorption of the drug.
A) Do not lie down for at least 30 minutes
This option is correct as it directly aligns with the recommended administration guidelines for alendronate. Patients are advised to remain upright for at least 30 minutes to reduce the risk of esophageal problems and to enhance the medication's effectiveness.
B) Take with food or milk
This option is incorrect because alendronate should be taken on an empty stomach, typically in the morning, with a full glass of water. Taking it with food or milk can significantly decrease its absorption and efficacy.
C) May cause drowsiness
This option is also incorrect as alendronate is not known to cause drowsiness. Its side effects are more related to gastrointestinal discomfort rather than central nervous system effects.
D) If a dose is missed, take 2 doses the next day
This option is incorrect because the instructions for alendronate specify that if a dose is missed, the patient should skip the missed dose and return to their regular dosing schedule the following day. Taking two doses at once could increase the risk of side effects.
Conclusion
The correct answer, "Do not lie down for at least 30 minutes," is critical for safe and effective use of alendronate, ensuring proper drug absorption and reducing the risk of esophageal irritation. All other options misrepresent the essential guidelines for alendronate administration, either by suggesting inappropriate practices or incorrect information regarding side effects and dosing.